237 related articles for article (PubMed ID: 9522658)
21. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
Hedlund-Treutiger I; Henter JI; Elinder G
J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
[TBL] [Abstract][Full Text] [Related]
22. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
Kjaersgaard M; Edslev PW; Rosthøj S
Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
[TBL] [Abstract][Full Text] [Related]
24. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
O'Brien SH; Ritchey AK; Smith KJ
Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
[TBL] [Abstract][Full Text] [Related]
25. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?
Treutiger I; Rajantie J; Zeller B; Henter JI; Elinder G; Rosthøj S;
Arch Dis Child; 2007 Aug; 92(8):704-7. PubMed ID: 17460024
[TBL] [Abstract][Full Text] [Related]
26. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
Celik M; Bulbul A; Aydogan G; Tugcu D; Can E; Uslu S; Dursun M
J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408
[TBL] [Abstract][Full Text] [Related]
27. Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura.
Demircioğlu F; Saygi M; Yilmaz S; Oren H; Irken G
Pediatr Hematol Oncol; 2009; 26(7):526-32. PubMed ID: 19863209
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].
Masłowska E; Wysocki M; Michalak-Nowaczyk A
Pediatr Pol; 1996 Jan; 71(1):25-9. PubMed ID: 8966063
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic thrombocytopenic purpura (ITP) in children.
Baronci C; Pansini V; Funaro D; Coletti V; Caruso R; De Rossi G
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):665-7. PubMed ID: 16933259
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
[TBL] [Abstract][Full Text] [Related]
31. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
32. Prognostic variables in newly diagnosed childhood immune thrombocytopenia.
Ahmed S; Siddiqui AK; Shahid RK; Kimpo M; Sison CP; Hoffman MA
Am J Hematol; 2004 Dec; 77(4):358-62. PubMed ID: 15551294
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura.
van der Meer JW; van Beem RT; Robak T; Deptala A; Strengers PF
Vox Sang; 2011 Aug; 101(2):138-46. PubMed ID: 21749402
[TBL] [Abstract][Full Text] [Related]
34. The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura.
Koçak U; Gürsel T; Oztürk G
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):121-5. PubMed ID: 10759004
[TBL] [Abstract][Full Text] [Related]
35. Childhood acute immune thrombocytopenic purpura: 20 years later.
Blanchette VS; Carcao M
Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
[TBL] [Abstract][Full Text] [Related]
36. Initial management of children with newly diagnosed idiopathic thrombocytopenic purpura in the Nordic countries.
Treutiger I; Rajantie J; Zeller B; Elinder G; Rosthöj S; NOPHO ITP Working Group
Acta Paediatr; 2006 Jun; 95(6):726-31. PubMed ID: 16754555
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases.
Baronci C; Petrone A; Miano C; Lombardi A; Caniglia M; Russo LA; Luciani M; Pinto RM; Rana I; Caruso R; De Rossi G
Ann Ist Super Sanita; 1998; 34(4):457-61. PubMed ID: 10234876
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of immune thrombocytopenic purpura in Pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G].
Buteler C; Colombo H; Gabosi G; Manfredi MJ; Montero S; Pasquali MA; Rougier C; Sisti AM
Medicina (B Aires); 2001; 61(5 Pt 1):522-8. PubMed ID: 11721317
[TBL] [Abstract][Full Text] [Related]
39. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.
Son DW; Jeon IS; Yang SW; Cho SH
J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936
[TBL] [Abstract][Full Text] [Related]
40. [Long-term follow-up of chronic idiopathic thrombocytopenic purpura in children].
Amendola G; Danise P; D'Arco A
Pediatr Med Chir; 2000; 22(1):39-41. PubMed ID: 11387765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]